Cite
HARVARD Citation
Mariette, X. et al. (n.d.). THU0131 Tofacitinib (CP-690, 550), an oral janus kinase inhibitor: Analysis of malignancies across the rheumatoid arthritis clinical programme. Annals of the rheumatic diseases. p. 199. [Online].